(TPH) TRI Pointe Homes - Ratings and Ratios
Detached Homes, Attached Homes, Mortgage, Title, Insurance
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 34.8% |
| Value at Risk 5%th | 53.0% |
| Relative Tail Risk | -7.34% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.02 |
| Alpha | -13.68 |
| CAGR/Max DD | 0.54 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.399 |
| Beta | 0.585 |
| Beta Downside | 0.294 |
| Drawdowns 3y | |
|---|---|
| Max DD | 37.97% |
| Mean DD | 14.55% |
| Median DD | 10.40% |
Description: TPH TRI Pointe Homes January 12, 2026
Tri Pointe Homes, Inc. (NYSE: TPH) designs, builds, and sells single-family attached and detached homes across the United States, operating through a Homebuilding segment and a Financial Services segment that offers mortgage, title, escrow, and property-and-casualty insurance solutions. Sales are conducted via company-owned representatives and independent brokers, and the firm retains ownership of many of its development lots.
Key recent metrics (2023) include: total revenue of roughly $2.5 billion, an average selling price (ASP) of about $500 k per home, and a net profit margin near 5 %. The company reported a backlog of approximately $2.0 billion, indicating forward-looking demand. Sector-wide, TPH’s performance is sensitive to housing-starts data, mortgage-rate movements, and labor-cost pressures in the construction market-variables that have shown heightened volatility since early 2024.
For a deeper quantitative assessment, you might explore ValueRay’s analyst toolkit, which aggregates recent earnings revisions and price-target trends for TPH.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (310.1m TTM) > 0 and > 6% of Revenue (6% = 225.1m TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA -2.53pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 111.0% (prev 89.24%; Δ 21.80pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.06 (>3.0%) and CFO 300.7m <= Net Income 310.1m (YES >=105%, WARN >=100%) |
| Net Debt (473.9m) to EBITDA (453.2m) ratio: 1.05 <= 3.0 (WARN <= 3.5) |
| Current Ratio 24.46 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (89.6m) change vs 12m ago -5.32% (target <= -2.0% for YES) |
| Gross Margin 22.58% (prev 23.29%; Δ -0.71pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 76.82% (prev 94.13%; Δ -17.31pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| error: Interest Coverage Ratio cannot be calculated (needs EBITDA TTM and Interest Expense TTM) |
Altman Z'' 10.27
| (A) 0.84 = (Total Current Assets 4.34b - Total Current Liabilities 177.6m) / Total Assets 4.99b |
| (B) 0.66 = Retained Earnings (Balance) 3.30b / Total Assets 4.99b |
| (C) 0.09 = EBIT TTM 423.2m / Avg Total Assets 4.88b |
| (D) 1.96 = Book Value of Equity 3.30b / Total Liabilities 1.69b |
| Total Rating: 10.27 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 56.66
| 1. Piotroski 3.0pt |
| 2. FCF Yield 7.55% |
| 3. FCF Margin 7.23% |
| 4. Debt/Equity 0.38 |
| 5. Debt/Ebitda 1.05 |
| 6. ROIC - WACC (= 1.18)% |
| 7. RoE 9.36% |
| 8. Rev. Trend -12.40% |
| 9. EPS Trend -47.70% |
What is the price of TPH shares?
Over the past week, the price has changed by +13.74%, over one month by +4.12%, over three months by +9.55% and over the past year by -3.12%.
Is TPH a buy, sell or hold?
- Strong Buy: 5
- Buy: 0
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the TPH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 38.2 | 8.9% |
| Analysts Target Price | 38.2 | 8.9% |
| ValueRay Target Price | 39.3 | 12.1% |
TPH Fundamental Data Overview January 15, 2026
P/E Forward = 14.881
P/S = 0.8315
P/B = 0.928
P/EG = 1.145
Revenue TTM = 3.75b USD
EBIT TTM = 423.2m USD
EBITDA TTM = 453.2m USD
Long Term Debt = 1.18b USD (from longTermDebt, last quarter)
Short Term Debt = 118.2m USD (from shortTermDebt, last fiscal year)
Debt = 1.27b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 473.9m USD (from netDebt column, last quarter)
Enterprise Value = 3.59b USD (3.12b + Debt 1.27b - CCE 792.0m)
Interest Coverage Ratio = unknown (Ebit TTM 423.2m / Interest Expense TTM 0.0)
EV/FCF = 13.25x (Enterprise Value 3.59b / FCF TTM 271.3m)
FCF Yield = 7.55% (FCF TTM 271.3m / Enterprise Value 3.59b)
FCF Margin = 7.23% (FCF TTM 271.3m / Revenue TTM 3.75b)
Net Margin = 8.27% (Net Income TTM 310.1m / Revenue TTM 3.75b)
Gross Margin = 22.58% ((Revenue TTM 3.75b - Cost of Revenue TTM 2.90b) / Revenue TTM)
Gross Margin QoQ = 21.46% (prev 21.03%)
Tobins Q-Ratio = 0.72 (Enterprise Value 3.59b / Total Assets 4.99b)
Interest Expense / Debt = 0.77% (Interest Expense 9.76m / Debt 1.27b)
Taxrate = 27.00% (20.8m / 76.9m)
NOPAT = 309.0m (EBIT 423.2m * (1 - 27.00%))
Current Ratio = 24.46 (Total Current Assets 4.34b / Total Current Liabilities 177.6m)
Debt / Equity = 0.38 (Debt 1.27b / totalStockholderEquity, last quarter 3.30b)
Debt / EBITDA = 1.05 (Net Debt 473.9m / EBITDA 453.2m)
Debt / FCF = 1.75 (Net Debt 473.9m / FCF TTM 271.3m)
Total Stockholder Equity = 3.31b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.35% (Net Income 310.1m / Total Assets 4.99b)
RoE = 9.36% (Net Income TTM 310.1m / Total Stockholder Equity 3.31b)
RoCE = 9.43% (EBIT 423.2m / Capital Employed (Equity 3.31b + L.T.Debt 1.18b))
RoIC = 7.09% (NOPAT 309.0m / Invested Capital 4.36b)
WACC = 5.90% (E(3.12b)/V(4.39b) * Re(8.07%) + D(1.27b)/V(4.39b) * Rd(0.77%) * (1-Tc(0.27)))
Discount Rate = 8.07% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.10%
[DCF Debug] Terminal Value 85.13% ; FCFF base≈315.2m ; Y1≈281.9m ; Y5≈238.7m
Fair Price DCF = 78.41 (EV 7.21b - Net Debt 473.9m = Equity 6.74b / Shares 86.0m; r=5.90% [WACC]; 5y FCF grow -13.04% → 2.90% )
EPS Correlation: -47.70 | EPS CAGR: -45.60% | SUE: -4.0 | # QB: 0
Revenue Correlation: -12.40 | Revenue CAGR: -8.85% | SUE: 3.54 | # QB: 2
EPS next Quarter (2026-03-31): EPS=0.21 | Chg30d=-0.055 | Revisions Net=-1 | Analysts=4
EPS next Year (2026-12-31): EPS=2.28 | Chg30d=-0.097 | Revisions Net=-3 | Growth EPS=-19.5% | Growth Revenue=-7.5%
Additional Sources for TPH Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle